Work

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7

Year: 2006

Type: article

Abstract: It has recently been discovered that a single-site, clonal, gain-of-function mutation of the tyrosine kinase JAK2 (JAK2 V617F) is present in myeloid cells from the majority of patients with chronic myeloproliferative disorders (MPDs).[1][1],[2][2] In addition, JAK2 V617F can be detected in some

Source: Blood

DOI: 10.1182/blood-2005-09-3644

Authors: Stefan Fröhling, Daniel B. Lipka, Sabine Kayser, Claudia Scholl, Richard F. Schlenk, Hartmut Döhner, D. Gary Gilliland, Ross L. Levine, Konstanze Döhner

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2025348347

FWCI: 4.806

Cites: 10

Cited by: 57

Related to: 10